The company, whose history includes pharma bad-boy Martin Shkreli and a trip into Chapter 11 bankruptcy, had hoped the National Institutes of Health-sponsored study would help it win FDA emergency use authorization.
The company, whose history includes pharma bad-boy Martin Shkreli and a trip into Chapter 11 bankruptcy, had hoped the National Institutes of Health-sponsored study would help it win FDA emergency use authorization.
